|Mr. Fulvio Citaredo||Chief Exec. Officer and Director||90.83k||N/A||55|
|Dr. Maria Teresa Ciccone||Financial Reporting Officer||N/A||N/A||39|
|Mr. Bernardo Verrengia||Chief Quality Officer||N/A||N/A||68|
|Mr. Toni Valente||CMO Gen. Mang.||N/A||N/A||56|
Pierrel S.p.A. provides contract research and manufacturing services to the pharmaceutical, bio-pharmaceutical, and life science industries worldwide. It is involved in the development of various types of drugs, such as tube vials, bottles, ampoules, drops, sprays, syrups, gels, creams, ointments, and tablets; and production of active ingredients, including active substances and pharmaceutical formulations, as well as develops and manufactures dental anesthetics under the Orabloc brand name. The company also discovers medicinal product candidates; and repositions existing drugs for new therapeutic indications, and clinical research. In addition, it provides consulting services for clinical and regulatory development programs, as well as operational services for the execution of international phase I-IV and non-interventional clinical trials. Pierrel S.p.A. is based in Capua, Italy.
Pierrel S.p.A.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.